SkinBioTherapeutics plc (LON:SBTX - Get Free Report)'s share price traded up 10.6% during trading on Tuesday . The stock traded as high as GBX 23.50 ($0.31) and last traded at GBX 23.50 ($0.31). 1,576,604 shares traded hands during mid-day trading, an increase of 46% from the average session volume of 1,077,583 shares. The stock had previously closed at GBX 21.25 ($0.28).
SkinBioTherapeutics Stock Performance
The business has a 50 day moving average price of GBX 21.63 and a two-hundred day moving average price of GBX 18.38. The stock has a market cap of £59.62 million, a P/E ratio of -16.05 and a beta of 2.01. The company has a quick ratio of 10.01, a current ratio of 0.93 and a debt-to-equity ratio of 27.57.
SkinBioTherapeutics (LON:SBTX - Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported GBX (0.46) (($0.01)) earnings per share for the quarter. SkinBioTherapeutics had a negative return on equity of 115.86% and a negative net margin of 237.95%.
About SkinBioTherapeutics
(
Get Free Report)
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Read More
Before you consider SkinBioTherapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SkinBioTherapeutics wasn't on the list.
While SkinBioTherapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
